A Phase II Clinical Trial of Fludarabine and Cyclophosphamide Followed by Thalidomide for Angioimmunoblastic Lymphoma (AITL), an NCRI Clinical Trial. CRUK C17050/A5671
| Autor: | Townsend, William M *, Johnson, Roderick J., Counsell, Nicholas *, Shah, Humra *, Pottinger, Bryson *, Evans, Katy *, Wickham, Caroline *, Smith, Paul *, Claudius, Rudin * |
|---|---|
| Zdroj: | In Blood 16 November 2012 120(21):3642-3642 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|